 LOS ANGELES, Aug. 5, 2021 PRNewswire -- Glancy Prongay Murray LLP GPM reminds investors of the upcoming August 24, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Athira Pharma, Inc. Athira or the Company NASDAQ: ATHA: a common stock pursuant andor traceable to the registration statement and prospectus collectively, the Registration Statement issued in connection with the Companys September 2020 initial public offering IPO or the Offering; andor b securities between September 18, 2020 and June 17, 2021 , inclusive the Class Period. If you suffered a loss on your Athira investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at 